Cite
HARVARD Citation
Hellio le Graverand, M. et al. (2013). A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Annals of the rheumatic diseases. 72 (2), pp. 187-195. [Online].